Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 12
Item hits:
Issue DateTitleAuthor(s)
1-Jan-2014Pirfenidone in idiopathic pulmonary fibrosis: expert panel discussion on the management of drug-related adverse eventsCostabel, U; Bendstrup, E; Cottin, V; Dewint, P; Egan, JJJ, et al
1-Feb-2019Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A multidisciplinary approach to address challenges and opportunitiesFischer, A; Strek, ME; Cottin, V; Dellaripa, PF; Bernstein, EJ, et al
20-Aug-2018Investigating the effects of nintedanib on biomarkers of extracellular matrix turnover in patients with IPF: design of the randomised placebo-controlled INMARK®trialMaher, TM; Stowasser, S; Nishioka, Y; White, ES; Cottin, V, et al
19-Nov-2018Long-term safety of pirfenidone: results of the prospective, observational PASSPORT studyCottin, V; Koschel, D; Günther, A; Albera, C; Azuma, A, et al
1-Feb-2019Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A multidisciplinary approach to address challenges and opportunitiesFischer, A; Strek, ME; Cottin, V; Dellaripa, PF; Bernstein, EJ, et al
31-Aug-2017Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study.Walsh, SLF; Maher, TM; Kolb, M; Poletti, V; Nusser, R, et al
1-Jan-2019Lung function outcomes in the INPULSIS<sup>®</sup> trials of nintedanib in idiopathic pulmonary fibrosisBrown, KK; Flaherty, KR; Cottin, V; Raghu, G; Inoue, Y, et al
14-Jun-2016Acute Exacerbation of Idiopathic Pulmonary Fibrosis: An International Working Group ReportCollard, HR; Ryerson, CJ; Corte, TJ; Jenkins, G; Kondoh, Y, et al
1-May-2018Statin therapy and outcomes in trials of nintedanib in idiopathic pulmonary fibrosisKreuter, M; Costabel, U; Richeldi, L; Cottin, V; Wijsenbeek, M, et al
4-Sep-2018Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trial.Maher, TM; Corte, TJ; Fischer, A; Kreuter, M; Lederer, DJ, et al